- $657.53m
- $568.51m
- $5.72m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.06 | 4.78 | 4.78 | 5.75 | 5.72 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.32 | 18.1 | 79.4 | 112 | 121 |
Operating Profit | -6.26 | -13.3 | -74.6 | -107 | -116 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.58 | -14.4 | -110 | -105 | -110 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.58 | -14.4 | -101 | -105 | -111 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.58 | -14.4 | -101 | -105 | -111 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.9 | -49.5 | -103 | -105 | -111 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.264 | -0.547 | -2.06 | -1.15 | -1.05 |
Dividends per Share |